{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-025086","form_type":"8-K","ticker":"AXSM","cik":"0001579428","company_name":"Axsome Therapeutics, Inc.","filed_at":"2022-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.257515+00:00","generated_at":"2026-06-21T20:11:16.116068+00:00","sec_items":["2.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Axsome completes final closing of Sunosi acquisition from Jazz Pharmaceuticals on Nov 14, 2022","bullets":["Final closing of ex-U.S. assets for Sunosi occurred Nov 14, 2022, satisfying closing conditions.","Initial U.S. closing had occurred on May 9, 2022, as previously reported.","Acquisition covers worldwide rights to Sunosi excluding 12 Asian markets (e.g., China, Korea, Japan).","Financial statements and pro forma information were previously filed on July 21, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-025086","json":"https://secwatch.observer/filing/0000950170-22-025086.json","markdown":"https://secwatch.observer/filing/0000950170-22-025086.md","text":"https://secwatch.observer/filing/0000950170-22-025086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1579428/000095017022025086/0000950170-22-025086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1579428/000095017022025086/axsm-20221114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T20:11:16.116068+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e7f87a21c7314bf94e908345349f0b4587bf7fe2","claim":"Axsome Therapeutics, Inc. completed an acquisition involving Jazz Pharmaceuticals plc (closed 2022-11-14).","evidence_excerpt":"The final closing contemplated by the Purchase Agreement (i.e., the conveyance of the ex-U.S. assets) occurred on November 14, 2022","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1579428/000095017022025086/0000950170-22-025086-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Jazz Pharmaceuticals plc"},{"label":"Closing","value":"2022-11-14"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}